Sign in
4

Changes in Ownership

MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-09-006450

Options or other derivatives

  • Sr. VP, Drug Development acquired 44,616 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Koya Keizo · Sr. VP, Drug Development

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2009-04-13 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +44,616 44,616 D
Loading xslF345X03/edgar.xml…